Toggle navigation
P
ROFILES
Search
Features
2020
BU CTSI
BU CTSI Home
About Us
Research Resources
Funding Opportunities
Community
News and Events
Help
About / FAQ
How to Request a Profile
Request Help
Log in to Profiles
Search Results (7)
More Search Options
Click the
Why
column to see why an item matched the search.
Match
Type
Why
Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.
Academic Article
Why?
Preclinical efficacy of MEK inhibition in Nras-mutant AML.
Academic Article
Why?
Protein kinase Cd is a therapeutic target in malignant melanoma with NRAS mutation.
Academic Article
Why?
Concordance of somatic mutation profiles (BRAF,NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples.
Academic Article
Why?
Yang, Shi
Person
Why?
Chen, Shuyang
Person
Why?
Huang, Tannie
Person
Why?
First
Prev
Page
of 1
Next
Last
Per PageĀ
15
25
50
100
Highlights
Search Criteria
NRAS
Search Options
Modify Search
Search Other Institutions
Filter by Type
All
(7)
People
(3)
Research
(4)